23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
Consumer genomics companies have endeavored to reach out to minority communities with sometimes contentious results.
In 125,000 de-identified Invitae customers with and without a personal or family history of cancer, 23andMe's DTC test would have missed almost 90 percent of BRCA mutations.
The AP's Candace Choi writes that the diet and nutrition advice she received from two direct-to-consumer genetic testing firms was broad.
My Gene Counsel's confirmatory testing program is the latest example of how the healthcare system is adapting to consumers' growing appetite for genetic testing.
23andMe is now offering a type 2 diabetes risk test, according to MIT's Technology Review.
Healthcare providers continue to worry about the impact of 23andMe's health risk reports but there is also growing acceptance of the DTC testing model.
At-home genetic tests can uncover family secrets and lead those who uncover them to seek out support groups, the Boston Globe reports.
The revelation that Family Tree DNA has been working with law enforcement has some worried about a negative impact on the industry.
The New York Times warns in an editorial that 23andMe health risk tests may not provide useful information.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.